Distal acquired demyelinating symmetric (DADS) neuropathy associated with colorectal adenocarcinoma

Paraneoplastic neuropathies are well recognized as a remote effect of cancer, and subacute sensory neuronopathy is a recognized syndrome. Demyelinating neuropathies are relatively rare. Distal acquired demyelinating symmetric (DADS) neuropathy associated with lymphoproliferative disease has been reported previously. We present the association of DADS neuropathy with solid tumor.

[1]  M. Frisch,et al.  Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay , 2013, Molecular Cancer.

[2]  A. Steck,et al.  Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy , 2013, Neurology.

[3]  G. Lauria,et al.  A case of multifocal motor neuropathy with conduction block associated with gastric and lung adenocarcinoma , 2012, Journal of the peripheral nervous system : JPNS.

[4]  G. Sobue,et al.  Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. , 2011, Current opinion in neurology.

[5]  F. Bombelli,et al.  Non‐anti‐MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases , 2011, European journal of neurology.

[6]  Wenbiao Chen,et al.  Centromere protein F and survivin are associated with high risk and a poor prognosis in colorectal gastrointestinal stromal tumours , 2011, Journal of Clinical Pathology.

[7]  J. Honnorat,et al.  Spectrum of paraneoplastic disease associated with lymphoma , 2011, Neurology.

[8]  T. Brannagan.  Current treatments of chronic immune‐mediated demyelinating polyneuropathies , 2009, Muscle & nerve.

[9]  M. Rubin,et al.  Paraneoplastic Neurological Syndromes: A Review , 2009, The neurologist.

[10]  T. Maisonobe,et al.  Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[11]  J. Chawla,et al.  Gastric Carcinoma Presenting With Chronic Inflammatory Demyelinating Polyneuropathy , 2006 .

[12]  K. Kleopa,et al.  Multifocal motor neuropathy with conduction block associated with metastatic lymphoma of the nervous system , 2006, Journal of Neuro-Oncology.

[13]  J. Finsterer.  Treatment of immune‐mediated, dysimmune neuropathies , 2005, Acta neurologica Scandinavica.

[14]  J. Honnorat,et al.  Recommended diagnostic criteria for paraneoplastic neurological syndromes , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  G. Deuschl,et al.  Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodies , 2003, Muscle & nerve.

[16]  R. Barohn,et al.  Clinical spectrum of chronic acquired demyelinating polyneuropathies , 2001, Muscle & nerve.

[17]  M. Magistris,et al.  Paraneoplastic anti‐CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy , 2001, Annals of neurology.

[18]  G. Gronseth,et al.  Distal acquired demyelinating symmetric neuropathy , 2000, Neurology.

[19]  J. B. Rattner,et al.  High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. , 1997, Clinical and investigative medicine. Medecine clinique et experimentale.

[20]  Y. Matsuzawa,et al.  Chronic inflammatory demyelinating polyneuropathy accompanied by hepatocellular carcinoma. , 1997, Internal medicine.

[21]  S. Scherer,et al.  Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma , 1996, Neurology.

[22]  B. Laurent,et al.  Chronic inflammatory demyelinating polyneuropathy associated with carcinoma. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[23]  J. Vallat,et al.  Non-Hodgkin malignant lymphomas and peripheral neuropathies--13 cases. , 1995, Brain : a journal of neurology.

[24]  T. Noguchi,et al.  Immunoreactive myelin basic protein in tumor cells associated with carcinomatous neuropathy. , 1985, American Journal of Clinical Pathology.

[25]  C. Bell,et al.  Identification of the Schwann cell as a peripheral nervous system cell possessing a differentiation antigen expressed by a human lung tumor. , 1977, Journal of immunology.